NexgenRx Inc. has completed a private placement financing in which it issued 1,700,000 of its common shares at 25 Canadian cents apiece for aggregate gross proceeds of C$425,000.

The company said the proceeds of the offering will be used to fund future technology, product and software development. The proceeds will also be used to provide general working capital for 2018.